Evidence for Step Therapy in Diabetic Macular Edema.
作者信息
Musch David C, Chew Emily Y
机构信息
From the Department of Ophthalmology and Visual Sciences, Medical School, and the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (D.C.M.); and the Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD (E.Y.C.).
出版信息
N Engl J Med. 2022 Aug 25;387(8):751-752. doi: 10.1056/NEJMe2208454. Epub 2022 Jul 14.
Abstract
摘要
相似文献
1
Evidence for Step Therapy in Diabetic Macular Edema.糖尿病性黄斑水肿阶梯治疗的证据。
N Engl J Med. 2022 Aug 25;387(8):751-752. doi: 10.1056/NEJMe2208454. Epub 2022 Jul 14.
2
Treatments for Diabetic Macular Edema: Past, Present, and Future.糖尿病性黄斑水肿的治疗：过去、现在与未来
Ophthalmic Surg Lasers Imaging Retina. 2016 Sep 1;47(9):794-800. doi: 10.3928/23258160-20160901-01.
3
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.《糖尿病性黄斑水肿管理的第一议定书实用经验》
Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20.
4
Treatment options for diffuse diabetic macular edema.弥漫性糖尿病性黄斑水肿的治疗选择。
Eur J Ophthalmol. 2011;21 Suppl 6:S45-50. doi: 10.5301/EJO.2010.6054.
5
[Has laser in diabetic macular edema become a shot in the dark?].
Ugeskr Laeger. 2017 Nov 13;179(23).
6
Diabetic Macular Edema - Diagnostics and Treatment Guidelines.糖尿病性黄斑水肿 - 诊断和治疗指南。
Cesk Slov Oftalmol. 2023 Fall;79(5):225-235. doi: 10.31348/2023/27.
7
Intravitreal injections and diabetic macular edema: actual and new therapeutic options.玻璃体内注射与糖尿病性黄斑水肿：现有及新的治疗选择。
Curr Diabetes Rev. 2013 Nov;9(6):491-8. doi: 10.2174/15733998113096660083.
8
Combined therapy for diabetic macular edema.糖尿病性黄斑水肿的联合治疗
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):315-20. doi: 10.4103/0974-9233.120014.
9
DIABETIC MACULAR EDEMA.糖尿病性黄斑水肿
Rom J Ophthalmol. 2015 Jul-Sep;59(3):133-6.
10
Panretinal photocoagulation and intravitreal triamcinolone acetonide injection in four diabetic patients.
Retina. 2005 Jul-Aug;25(5):675; author reply 675-6. doi: 10.1097/00006982-200507000-00027.
引用本文的文献
1
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies.糖尿病血管病变：分子机制与治疗策略。
Signal Transduct Target Ther. 2023 Apr 10;8(1):152. doi: 10.1038/s41392-023-01400-z.
本文引用的文献
1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.阿柏西普单药治疗或贝伐单抗一线治疗糖尿病性黄斑水肿。
N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14.
2
Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug Prices.阶梯治疗的平衡之举——在应对高昂药价的同时保护患者。
N Engl J Med. 2022 Mar 10;386(10):901-904. doi: 10.1056/NEJMp2117582. Epub 2022 Mar 5.
3
Treatment of Neovascular Age-Related Macular Degeneration: An Economic Cost-Risk Analysis of Anti-Vascular Endothelial Growth Factor Agents.新生血管性年龄相关性黄斑变性的治疗：抗血管内皮生长因子药物的经济成本-风险分析
Ophthalmol Retina. 2022 Mar;6(3):205-212. doi: 10.1016/j.oret.2021.08.009. Epub 2021 Aug 25.
4
Clinical Registries in Ophthalmology.眼科学临床注册。
Ophthalmology. 2019 May;126(5):655-662. doi: 10.1016/j.ophtha.2018.12.030. Epub 2018 Dec 17.
5
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.阿柏西普、贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿的成本效益：来自糖尿病视网膜病变临床研究网络比较疗效试验的分析
JAMA Ophthalmol. 2016 Aug 1;134(8):888-96. doi: 10.1001/jamaophthalmol.2016.1669.
6
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿：一项比较疗效随机临床试验的两年结果。
Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27.
7
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿。
N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.
8
The ethics of 'fail first': guidelines and practical scenarios for step therapy coverage policies.“先失败”的伦理：阶梯式治疗覆盖政策的指南和实际情况。
Health Aff (Millwood). 2014 Oct;33(10):1779-85. doi: 10.1377/hlthaff.2014.0516.
Zotero 插件